SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 1-A - Offering Statement [Regulation A]:
SEC Accession No. 0001615774-18-002234
Filing Date
2018-03-30
Accepted
2018-03-30 16:49:48
Documents
8

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 1-A  
1 primary_doc.xml 1-A 15388
2 PART II AND III s109444_partiiandiii.htm PART II AND III 662747
3 EX1A-11 CONSENT s109444_ex11-1.htm EX1A-11 CONSENT 3658
4 GRAPHIC s109444_img1.jpg GRAPHIC 5347
5 GRAPHIC s109444_img2.jpg GRAPHIC 61528
6 GRAPHIC s109444_img3.jpg GRAPHIC 70076
7 GRAPHIC s109444_img4.jpg GRAPHIC 54389
8 GRAPHIC s109444_img5.jpg GRAPHIC 38143
  Complete submission text file 0001615774-18-002234.txt   999481
Mailing Address 1461 FORD STREET REDLANDS CA 92373
Business Address 1461 FORD STREET REDLANDS CA 92373 951-316-9002
ADiTx Therapeutics, Inc. (Filer) CIK: 0001726711 (see all company filings)

IRS No.: 823204328 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 1-A | Act: 33 | File No.: 024-10825 | Film No.: 18726505